InvestorsHub Logo
Followers 11
Posts 690
Boards Moderated 0
Alias Born 11/24/2015

Re: None

Tuesday, 06/06/2023 1:09:10 PM

Tuesday, June 06, 2023 1:09:10 PM

Post# of 462251
A pretty good 2023 aspirational list from a poster on the YMB. Let's keep track on how many the company delivers by EOY.

"Data catalysts between now and end of year. Full Phase 3 AD release. Peer review. Multiple country NDAs for A2-73 for the treatment of AD. Rett Phase 2/3 Data Release. Rett NDA. I would like to see Anavex, during next earnings call, confirm commercialization (manufacturing plans and sales distribution) strategy for A2-73 for AD and Rett."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News